As part of our coverage of the 2017 American Society of Hematology (ASH) meeting in Atlanta, Dr. Srdan Verstovsek, an MPN expert and researcher from MD Anderson Cancer Center, provides an update on the latest news from the conference. Dr. Verstovsek provides details about a new treatment being studied for anemia in patients with myelofibrosis as well as the two-year results of a European study of interferon for polycythemia vera (PV) treatment. Tune in to learn more.
An Interferon Update From ASH 2017 From an MPN Expert
